Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 19. November 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 9155  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 183094  
   
Cancer-associated fibroblasts and extracellular matrix remodeling driving drug resistance and immune evasion in bladder cancer: research progress.
Front Immunol
Lu P, Zhou L.
PMID: 43054729 [PubMed - indexed for MEDLINE]


Closing the loop in PSMA radiopharmaceutical therapy for prostate cancer: from eligibility to decision-validated treatment.
Front Med (Lausanne)
Gambini JP.
PMID: 43054230 [PubMed]


Secondary Analysis of a Randomized Controlled Trial of Adjuvant Chemotherapy by PSA Response Following Radiotherapy.
Cancer Med
Mihalcik SA, Regan MM, Rosenthal SA, Bubley GJ, Pienta KJ, Gomella LG, Hartford AC, Michalski JM, Rajan R, McDonald AM, Dominello MM, Grignon D, Jones CU, Atkins JN, Moughan J, Sandler HM, Kaplan ID.
PMID: 43053607 [PubMed - indexed for MEDLINE]


Intelligent Prediction of WHO/ISUP Grade in Clear-Cell Renal Cell Carcinoma Using CT-Based Fusion Delta Features: A Multicenter Study with Biological Interpretability Exploration.
Acad Radiol
Wang L, Wang Z, Xu J, Li G, Xu R, Wang J, Lin F, Xi X, Kang X, Wu J, Ma H, Guo H.
PMID: 43053510 [PubMed - as supplied by publisher]


Applications of dendrimers for prostate cancer gene therapy: current status and future perspectives.
Nanomedicine (Lond)
Kasurka B, Serry Moursy E, Dufès C.
PMID: 43053339 [PubMed - as supplied by publisher]


The prognostic impact of variant histology timing in bladder cancer: a comparative analysis of primary and secondary detection.
BMC Urol
Dama M, Ahmadzada J, Efiloglu O, Bozkurt YE, Iplikci A, Nuroglu MT, Turan T, Yildirim A.
PMID: 43052964 [PubMed - indexed for MEDLINE]


Systemic immune-inflammation index, but not neutrophil-to-lymphocyte ratio, is a predictor for detecting clinically significant prostate cancer at first biopsy.
BMC Urol
Lee JW, Cho MC.
PMID: 43052936 [PubMed - indexed for MEDLINE]


Early-life recurrent antibiotic use and risks of adult kidney cancer and sex-specific cancers: a prospective cohort study in the UK Biobank.
BMC Cancer
Peng J, Wang X, Wang J, Zhu D, Sun X, Zhen X.
PMID: 43052882 [PubMed - indexed for MEDLINE]


Perioperative Systemic Therapies for Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Network Meta-analysis.
Target Oncol
Matsukawa A, Mori K, Yanagisawa T, Miyajima K, Enei Y, Fukuokaya W, Ito K, Tsuzuki S, Cormio A, Miszczyk M, Pradere B, Moschini M, Shariat SF, Miki J, Kimura T.
PMID: 43052561 [PubMed - as supplied by publisher]


French AFU Cancer Committee Guidelines - Update 2026-2028: Penile cancer.
Fr J Urol
Neuville P, Escoffier A, Goujon A, Rocher L, Fléchon A, Branger N, Camparo P, Levy S, Savoie PH, Murez T, Roupret M.
PMID: 43051713 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Testicular germ cell cancer.
Fr J Urol
Murez T, Fléchon A, Branger N, Savoie PH, Rocher L, Camparo P, Neuville P, Escoffier A, Levy S, Goujon A, Roupret M.
PMID: 43051711 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Upper urinary tract urothelial tumors (UTUC).
Fr J Urol
Roumiguié M, Leon P, Xylinas E, Thibault C, Seisen T, Prost D, Allory Y, Bajeot AS, Pradère B, Neuzillet Y, Marcq G, Audenet F, Borchiellini D, Gabriel PE, Masson-Lecomte A, Roupret M.
PMID: 43051710 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Muscle-invasive bladder tumors (MIBC).
Fr J Urol
Roumiguié M, Marcq G, Bajeot AS, Allory Y, Borchiellini D, Sargos P, Leon P, Masson-Lecomte A, Neuzillet Y, Audenet F, Gabriel PE, Xylinas E, Pradère B, Prost D, Thibault C, Seisen T, Roupret M.
PMID: 43051709 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Prostate cancer - Diagnosis and management of localized disease.
Fr J Urol
Ploussard G, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Dariane C, Mathieu R, Rozet F, Peyrottes A, Roubaud G, Renard-Penna R, Sargos P, Supiot S, Turpin L, Rouprêt M.
PMID: 43051708 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Non-muscle-invasive bladder tumors (NMIBC).
Fr J Urol
Roumiguié M, Pradère B, Bajeot AS, Leon P, Xylinas E, Allory Y, Marcq G, Prost D, Neuzillet Y, Thibault C, Gabriel PE, Borchiellini D, Masson-Lecomte A, Seisen T, Audenet F, Roupret M.
PMID: 43051707 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Kidney cancer.
Fr J Urol
Bigot P, Khene ZE, Margue G, Albiges L, Barthelemy P, Bernhard JC, Correas JM, De Vergie S, Doumerc N, Ferragu M, Ingels A, Ouzaïd I, Pettenati C, Rioux-Leclercq N, Chapet O, Waeckel T, Boissier R, Rourpret M.
PMID: 43051705 [PubMed - indexed for MEDLINE]


French AFU Cancer Committee Guidelines - Update 2026-2028: Prostate Cancer - Treatment of relapse and metastatic disease.
Fr J Urol
Ploussard G, Dariane C, Mathieu R, Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Rozet F, Peyrottes A, Renard-Penna R, Sargos P, Supiot S, Turpin L, Roubaud G, Rouprêt M, Cancer Committee of the French Association of Urology.
PMID: 43051704 [PubMed - indexed for MEDLINE]


Single- Versus Two-Fraction HDR Brachytherapy Boost for Prostate Cancer: Long-Term Oncologic and Toxicity Outcomes.
Pract Radiat Oncol
Goñi A, Sevilla M, Larruskain M, Eguiguren M, Perez A, de Urturi ES, Iceta U, Roura DA, Alberich M, Minguez J, Urraca JM, Querejeta A.
PMID: 43051583 [PubMed - as supplied by publisher]


Homologous recombination repair gene alterations in prostate cancer: expert recommendations for genetic and biomarker testing.
Curr Opin Urol
Shariat SF, Morgan TM, Wyatt AW, Mehra N, Lang J, Briers E, Liang S, Grimm MO.
PMID: 43050498 [PubMed - as supplied by publisher]


Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials.
PLoS Comput Biol
Italia M, Bordel-Vozmediano S, García Otero J, Calvo GF, Pérez-García VM.
PMID: 43050486 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 183094    Seite 1 von 9155  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1